MDT

NYSE Medtronic Plc

Sep 29, 2026 · 4:59 AM ET LAST TRADE Market Closed

$89.53 ↑ +0.03 (+0.03%) Trading Up from the previous close of $89.50

YTD change: -6.80%
vs 20-day SMA: -2.29%
vs 200-day SMA: +0.70%

Price ranges

Previous day

$87.52 $89.53

open $88.50 close $89.50

+$1.00 (+1.13%)

Today

$0.00 $0.00

$89.53

Past week

$87.12 $92.67

from $91.75 now $89.53

-$2.22 (-2.42%)

Past month

$87.12 $95.41

from $91.23 now $89.53

-$1.70 (-1.86%)

This year

$73.31 $105.50

from $96.06 now $89.53

-$6.53 (-6.80%)

Price & Performance

+3.76 (+4.39%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 34.1% away from all-time highs of $135.89
MDT is down 7% since the beginning of the year
MDT is down 5% over the past 12 months
MDT is down 2% over the past 1 month
1% of all MDT investors are betting against MDT
Number of investors short MDT has gone down 5% versus last month

MDT reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is -4.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $1.45

Earnings momentum -8.7% Quarterly EPS growth

Quarterly change -8.7%

Valuation

P/E ratio 21.75

Enterprise value $133.9B

Beta 0.50

Balance sheet & scale

Income$5.2M

Revenue$37.5B

Cash$8.8B

Debt$28.2M

Income / Debt 0.19×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Computer and Electronic Product Manufacturing

Market cap $114.5B

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Galway, Ireland.

Competitor comparison

Ticker	Company	Price	Change
TMO	Thermo Fisher Scientific Inc.	$678.60	+0.53%
ABT	Abbott Laboratories	$100.98	-0.31%
ISRG	Intuitive Surgical, Inc.	$414.79	+2.37%
BSX	Boston Scientific Corporation	$44.11	+0.43%
EW	Edwards Lifesciences Corporation	$86.83	+0.63%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.